China Resources Boya Bio pharmaceutical Group Co Ltd (300294)

Shenzhen
Currency in CNY
26.72
-0.42(-1.55%)
Closed·
300294 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected today
Fair Value
Day's Range
26.6727.15
52 wk Range
26.2841.98
Key Statistics
Edit
Bid/Ask
26.72 / 26.72
Prev. Close
26.72
Open
27.1
Day's Range
26.67-27.15
52 wk Range
26.28-41.98
Volume
4.76M
Average Volume (3m)
6.62M
1-Year Change
-19.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300294 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
33.88
Upside
+26.78%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years
Show more

China Resources Boya Bio pharmaceutical Group Co Ltd Company Profile

China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the blood product businesses in China. The company offers blood products, such as human coagulation, human prothrombin, human fibrinogen, human albumin, intravenous human immunoglobulin, and rabies immunoglobulin; and non-blood products. It provides bone polypeptide, oxytocin, heparin sodium, and posterior pituitary injection products; and metformin hydrochloride enteric-coated tablets, glimepiride tablets, calcium dobesilate products, and pioglitazone hydrochloride dispersible tablets. In addition, the company engages in research, development, production, and sales of anti-infective, diabetes, and cardiovascular and cerebrovascular drug; and distributes blood products. The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co.,Ltd. The company was founded in 1993 and is based in Fuzhou City, China.

Employees
1938
Market
China

Compare 300294 to Peers and Sector

Metrics to compare
300294
Peers
Sector
Relationship
P/E Ratio
35.0x28.2x−0.5x
PEG Ratio
0.45−1.010.00
Price/Book
1.8x2.2x2.6x
Price / LTM Sales
7.4x5.7x3.0x
Upside (Analyst Target)
26.3%18.8%48.7%
Fair Value Upside
Unlock19.5%9.2%Unlock

Analyst Ratings

5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 33.88
(+26.78% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.77%
Dividend Yield
1.69%
Industry Median 1.46%
Annualised payout
0.46
Paid unevenly
5-Years Growth
+16.36%
Growth Streak

Earnings

Latest Release
Mar 19, 2025
EPS / Forecast
-0.03 / 0.27
Revenue / Forecast
490.00M / --
EPS Revisions
Last 90 days

FAQ

What Is the China Resources Boya Bio pharmaceutical (300294) Stock Price Today?

The China Resources Boya Bio pharmaceutical stock price today is 26.72

What Stock Exchange Does China Resources Boya Bio pharmaceutical Trade On?

China Resources Boya Bio pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for China Resources Boya Bio pharmaceutical?

The stock symbol for China Resources Boya Bio pharmaceutical is "300294."

Does China Resources Boya Bio pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The China Resources Boya Bio pharmaceutical dividend yield is 1.72%.

What Is the China Resources Boya Bio pharmaceutical Market Cap?

As of today, China Resources Boya Bio pharmaceutical market cap is 13.47B.

What Is China Resources Boya Bio pharmaceutical's Earnings Per Share (TTM)?

The China Resources Boya Bio pharmaceutical EPS (TTM) is 0.77.

When Is the Next China Resources Boya Bio pharmaceutical Earnings Date?

China Resources Boya Bio pharmaceutical will release its next earnings report on 22 May 2025.

From a Technical Analysis Perspective, Is 300294 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has China Resources Boya Bio pharmaceutical Stock Split?

China Resources Boya Bio pharmaceutical has split 3 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.